Inventor
QI HONGYAN
US22 patents
⚠️ This page may combine multiple inventors who share the name “QI HONGYAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PTC THERAPEUTICS INC
13 patentsUS9879007B2Jan 30, 2018
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC18 citations93
US9617268B2Apr 11, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC32 citations93
US9586955B2Mar 7, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC22 citations93
US7767689B2Aug 3, 2010
Carboline derivatives useful in the treatment of cancer
PTC THERAPEUTICS INC40 citations92
US7601840B2Oct 13, 2009
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC39 citations92
US9914722B2Mar 13, 2018
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC12 citations84
US8372860B2Feb 12, 2013
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC12 citations83
US8367694B2Feb 5, 2013
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC12 citations83
US9271960B2Mar 1, 2016
Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
PTC THERAPEUTICS INC4 citations71
US10947231B2Mar 16, 2021
Processes for the preparation of substituted tetrahydro beta-carbolines
PTC THERAPEUTICS INC2 citations68
US11753407B2Sep 12, 2023
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations61
US10851101B2Dec 1, 2020
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations51
USRE47689ENov 5, 2019
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations51